Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,048 | 137 | 99.9% |
| Education | $2.69 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $379.57 | 21 | $0 (2021) |
| Novo Nordisk Inc | $293.74 | 21 | $0 (2022) |
| Amarin Pharma Inc. | $153.04 | 5 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $132.28 | 11 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $126.60 | 11 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $123.45 | 8 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $120.91 | 10 | $0 (2020) |
| Merck Sharp & Dohme LLC | $101.25 | 7 | $0 (2022) |
| GlaxoSmithKline, LLC. | $76.63 | 6 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $64.28 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.77 | 1 | Inspire Medical Systems, Inc. ($26.77) |
| 2023 | $25.54 | 1 | Inspire Medical Systems, Inc. ($25.54) |
| 2022 | $66.07 | 5 | Novo Nordisk Inc ($28.65) |
| 2021 | $385.38 | 25 | Novo Nordisk Inc ($76.17) |
| 2020 | $219.38 | 16 | Novo Nordisk Inc ($42.54) |
| 2019 | $419.37 | 24 | Amarin Pharma Inc. ($87.27) |
| 2018 | $488.79 | 31 | Amgen Inc. ($186.03) |
| 2017 | $419.39 | 35 | Sunovion Pharmaceuticals Inc. ($108.57) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: NEUROLOGY | ||||||
| 10/11/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: NEUROLOGY | ||||||
| 09/08/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.23 | General |
| 03/01/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.95 | General |
| Category: Cardiovascular | ||||||
| 02/16/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/15/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Diabetes | ||||||
| 01/12/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/07/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: PRIMARY CARE | ||||||
| 11/09/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Diabetes | ||||||
| 11/03/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 10/06/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/22/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: DIABETES | ||||||
| 08/03/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), VERQUVO, STEGLUJAN | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/20/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Diabetes | ||||||
| 07/08/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/19/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Diabetes | ||||||
| 05/14/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Diabetes | ||||||
| 03/30/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Cardiology | ||||||
| 03/23/2021 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Inflammation | ||||||
| 03/10/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.10 | General |
| Category: Cardiovascular | ||||||
| 03/02/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.49 | General |
| 02/25/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Diabetes | ||||||
| 02/23/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 890 | 1,484 | $218,960 | $101,340 |
| 2022 | 11 | 987 | 1,558 | $281,235 | $114,001 |
| 2021 | 14 | 1,314 | 2,074 | $361,295 | $156,666 |
| 2020 | 16 | 1,484 | 2,292 | $386,895 | $162,188 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 269 | 715 | $96,525 | $43,327 | 44.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 188 | 207 | $31,050 | $18,044 | 58.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 43 | 101 | $35,350 | $16,674 | 47.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 99 | 104 | $29,640 | $13,359 | 45.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 34 | $6,290 | $3,115 | 49.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 52 | 72 | $6,840 | $2,762 | 40.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 28 | $5,460 | $2,706 | 49.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 189 | 223 | $7,805 | $1,352 | 17.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 90 | 233 | $81,550 | $39,567 | 48.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 210 | 499 | $67,365 | $27,156 | 40.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 162 | 177 | $26,550 | $14,160 | 53.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 72 | 79 | $22,515 | $11,835 | 52.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 52 | 99 | $18,315 | $7,848 | 42.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 119 | 122 | $40,870 | $6,504 | 15.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 47 | 71 | $6,745 | $2,140 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 46 | $7,130 | $1,899 | 26.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $2,925 | $1,577 | 53.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 163 | 204 | $7,140 | $1,277 | 17.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 13 | $130.00 | $39.00 | 30.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 94 | 244 | $85,400 | $39,716 | 46.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 233 | 508 | $68,580 | $28,344 | 41.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 117 | 324 | $50,220 | $26,739 | 53.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 85 | 93 | $26,505 | $14,128 | 53.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 148 | 164 | $24,600 | $13,351 | 54.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 88 | 88 | $17,600 | $11,322 | 64.3% |
About Dr. Robert Bisel, DO
Dr. Robert Bisel, DO is a Internal Medicine healthcare provider based in Warren, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831150242.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Bisel, DO has received a total of $2,051 in payments from pharmaceutical and medical device companies, with $26.77 received in 2024. These payments were reported across 138 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,048).
As a Medicare-enrolled provider, Bisel has provided services to 4,675 Medicare beneficiaries, totaling 7,408 services with total Medicare billing of $534,196. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Warren, OH
- Active Since 03/28/2006
- Last Updated 01/02/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1831150242
Products in Payments
- Ozempic (Drug) $162.78
- Vascepa (Drug) $153.04
- ELIQUIS (Drug) $143.03
- Repatha (Biological) $137.34
- ENTRESTO (Drug) $111.06
- XARELTO (Drug) $109.68
- BROVANA (Drug) $98.22
- Prolia (Biological) $96.44
- XIFAXAN (Drug) $95.90
- JANUVIA (Drug) $75.02
- Corlanor (Drug) $59.52
- INSPIRE (Device) $52.31
- TRELEGY ELLIPTA (Drug) $49.75
- Aimovig (Biological) $45.34
- TRULICITY (Drug) $43.33
- Victoza (Drug) $37.24
- AVYCAZ (Drug) $34.73
- VRAYLAR (Drug) $28.39
- Otezla (Drug) $27.69
- TOUJEO (Biological) $27.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Warren
Dr. Thong Truong, Md, MD
Internal Medicine — Payments: $24,467
Rana Bilbeisi, D.o, D.O
Internal Medicine — Payments: $24,199
Jessie Alperin, M.d, M.D
Internal Medicine — Payments: $20,857
Dr. John Weippert, D.o, D.O
Internal Medicine — Payments: $20,569
Dr. Nitin Patel, Md, MD
Internal Medicine — Payments: $15,882
Dr. Badi Altawil, Md, MD
Internal Medicine — Payments: $15,752